Cystic fibrosis (CF) lung disease commences early in the disease progression and is the most common cause of mortality.
Measurement of lung volumes across the life course is critical to the diagnosis and management of lung disease. The aim of the study was to use the G…
Arsenic is the only environmental toxin that has been linked to both malignant and nonmalignant respiratory disease following ingestion, rather than…
Mosaic attenuation on expiratory chest computed tomography (CT) is common in early life cystic fibrosis (CF) and often referred to as "air trapping"
Early life rhinovirus infection influences the development of house-dust-mite induced lung disease in female, but not male mice
Several lipid biomarkers of early cystic fibrosis lung disease were identified, which point toward potential disease monitoring and therapeutic appro…
Clinical trials for the treatment of cystic fibrosis (CF) lung disease are important to test and optimise new therapeutic interventions.
Structural lung disease and neutrophil-dominated airway inflammation is present from 3 months of age in children diagnosed with cystic fibrosis after…
Head, BREATH Team
Sensitive and reliable tests are required to monitor lung disease severity in cystic fibrosis. A number of potential ... investigate how these tests…